
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+14
Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of therapies for neurodegenerative diseases and Oncology. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden circuitry of human biology to identify novel targets driving disease and focused patient recruitment for clinical development. Aitia has translated those insights into its Gemini Digital Twins (computational representations of disease), which the company is using to discover new breakthrough therapies
Data analytics,bioinformatics,genomics data,big data,causal ai,drug discovery,virtual patient,in silico trials,clinical trial,virtual patient,drug discovery,target discovery,multi-omic patient data,oncology,neurodegenerative disorders,gemini digital twins,digital twins,gemini,and generative ai
Aitia operates in the Biotechnology research industry.
Aitia's revenue is 11m - 100m
Aitia has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.